Search results
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 5 days agoA consistent trend was seen in a subset of adults age 65 and older, the company said in a statement. The trial involved about 11,400 patients age 12 and older, half of whom were given
Gateway - Quartz
Quartz· 13 hours agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks about receiving U.S ...
Gateway - Quartz
Quartz· 4 hours agoNovo Nordisk and Johnson & Johnson both announced billion-dollar deals to acquire heart treatments. Walgreens Boots Alliance stock fell slightly in pre-market trading Thursday ...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 11 hours agoThe fund owned 42,156 shares of the biopharmaceutical company’s stock after selling 1,011 shares during the period. CoreFirst Bank & Trust’s holdings in Pfizer were worth ...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 11 hours agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F filing with the Securities ...
Arcturus Therapeutics (NASDAQ:ARCT) Shares Gap Down to $31.00
ETF DAILY NEWS· 1 day agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $31.00, but opened ...
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Benzinga via Yahoo Finance· 4 days agoVaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23%...
Ables Iannone Moore & Associates Inc. Purchases New Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 11 hours agoAbles Iannone Moore & Associates Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent disclosure with ...
Cartesian Therapeutics (NASDAQ:RNAC) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 20 hours agoHC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $54.00 ...
Gateway - Quartz
Quartz· 18 hours agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
